HMGN1 and non-small cell lung carcinoma: Taken together, our present work, as well as our previous work on HMGN1 [14], suggested that the alarmin system, which consists of alarmins and their soluble or membrane-bound receptors, hold great potential as ideal biomarkers to predict prognosis, monitor disease progression, or even access therapeutic effects of NSCLC patients.